Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma

Abstract Background Mesenchymal stem/stromal cells (MSCs) have been acknowledged as the most important stromal cells in the bone marrow (BM) microenvironment for physiologic hematopoiesis and the concomitant hematologic malignancies. However, the systematic and detailed dissection of the biological...

Full description

Bibliographic Details
Main Authors: Yu Lu, Chaohui Zheng, Wenxia Zhang, Xuan Liu, Ziwei Zhou, Zhenzhen Wang, Huan Hua, Zhengrong Song, Xuejun Zhang, Shuyi Liu, Leisheng Zhang, Fuxu Wang
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-024-03308-2
_version_ 1827300855999627264
author Yu Lu
Chaohui Zheng
Wenxia Zhang
Xuan Liu
Ziwei Zhou
Zhenzhen Wang
Huan Hua
Zhengrong Song
Xuejun Zhang
Shuyi Liu
Leisheng Zhang
Fuxu Wang
author_facet Yu Lu
Chaohui Zheng
Wenxia Zhang
Xuan Liu
Ziwei Zhou
Zhenzhen Wang
Huan Hua
Zhengrong Song
Xuejun Zhang
Shuyi Liu
Leisheng Zhang
Fuxu Wang
author_sort Yu Lu
collection DOAJ
description Abstract Background Mesenchymal stem/stromal cells (MSCs) have been acknowledged as the most important stromal cells in the bone marrow (BM) microenvironment for physiologic hematopoiesis and the concomitant hematologic malignancies. However, the systematic and detailed dissection of the biological and transcriptomic signatures of BM-MSCs in multiple myeloma (MM) are largely unknown. Methods In this study, we isolated and identified BM-MSCs from 10 primary MM patients and 10 healthy donors (HD). On the one hand, we compared the multifaceted biological characteristics of the indicated two BM-MSCs, including biomarker expression pattern, multilineage differentiation potential, stemness and karyotyping, together with the cellular vitality and immunosuppressive property. On the other hand, we took advantage of RNA-SEQ and bioinformatics analysis to verify the similarities and differences at the transcriptomic level between MM-MSCs and HD-MSCs. Results As to biological phenotypes and biofunctions, MM-MSCs revealed conservation in immunophenotype, stemness and differentiation towards adipocytes and chondrocytes with HD-MSCs, whereas with impaired osteogenic differentiation potential, cellular vitality and immunosuppressive property. As to transcriptomic properties, MM-MSCs revealed multidimensional alterations in gene expression profiling and genetic variations. Conclusions Overall, our date systematic and detailed reflected the multifaceted similarities and variations between MM-MSCs and HD-MSCs both at the cellular and molecular levels, and in particular, the alterations of immunomodulation and cellular viability of MM-MSCs, which wound benefit the further exploration of the pathogenesis and new drug application (NDA) of multiple myeloma from the view of BM-MSCs.
first_indexed 2024-04-24T16:13:17Z
format Article
id doaj.art-6a09c832414e4a1897b0d796b120f689
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-04-24T16:13:17Z
publishDate 2024-03-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-6a09c832414e4a1897b0d796b120f6892024-03-31T11:36:07ZengBMCCancer Cell International1475-28672024-03-0124111310.1186/s12935-024-03308-2Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myelomaYu Lu0Chaohui Zheng1Wenxia Zhang2Xuan Liu3Ziwei Zhou4Zhenzhen Wang5Huan Hua6Zhengrong Song7Xuejun Zhang8Shuyi Liu9Leisheng Zhang10Fuxu Wang11Department of Hematology, Hebei Key Laboratory of Hematology, The Second Hospital of Hebei Medical UniversityDepartment of Otolaryngology, The Second Affiliated Hospital of Fujian Medical UniversityDepartment of Hematology, Hebei Key Laboratory of Hematology, The Second Hospital of Hebei Medical UniversityDepartment of Hematology, Hebei Key Laboratory of Hematology, The Second Hospital of Hebei Medical UniversityDepartment of Hematology, Hebei Key Laboratory of Hematology, The Second Hospital of Hebei Medical UniversityDepartment of Hematology, Hebei Key Laboratory of Hematology, The Second Hospital of Hebei Medical UniversityDepartment of Hematology, Hebei Key Laboratory of Hematology, The Second Hospital of Hebei Medical UniversityDepartment of Hematology, Hebei Key Laboratory of Hematology, The Second Hospital of Hebei Medical UniversityDepartment of Hematology, Hebei Key Laboratory of Hematology, The Second Hospital of Hebei Medical UniversityDepartment of Hematology, Hebei Key Laboratory of Hematology, The Second Hospital of Hebei Medical UniversityScience and Technology Innovation Center, The Fourth People’s Hospital of Jinan & The Teaching Hospital of Shandong First Medical UniversityDepartment of Hematology, Hebei Key Laboratory of Hematology, The Second Hospital of Hebei Medical UniversityAbstract Background Mesenchymal stem/stromal cells (MSCs) have been acknowledged as the most important stromal cells in the bone marrow (BM) microenvironment for physiologic hematopoiesis and the concomitant hematologic malignancies. However, the systematic and detailed dissection of the biological and transcriptomic signatures of BM-MSCs in multiple myeloma (MM) are largely unknown. Methods In this study, we isolated and identified BM-MSCs from 10 primary MM patients and 10 healthy donors (HD). On the one hand, we compared the multifaceted biological characteristics of the indicated two BM-MSCs, including biomarker expression pattern, multilineage differentiation potential, stemness and karyotyping, together with the cellular vitality and immunosuppressive property. On the other hand, we took advantage of RNA-SEQ and bioinformatics analysis to verify the similarities and differences at the transcriptomic level between MM-MSCs and HD-MSCs. Results As to biological phenotypes and biofunctions, MM-MSCs revealed conservation in immunophenotype, stemness and differentiation towards adipocytes and chondrocytes with HD-MSCs, whereas with impaired osteogenic differentiation potential, cellular vitality and immunosuppressive property. As to transcriptomic properties, MM-MSCs revealed multidimensional alterations in gene expression profiling and genetic variations. Conclusions Overall, our date systematic and detailed reflected the multifaceted similarities and variations between MM-MSCs and HD-MSCs both at the cellular and molecular levels, and in particular, the alterations of immunomodulation and cellular viability of MM-MSCs, which wound benefit the further exploration of the pathogenesis and new drug application (NDA) of multiple myeloma from the view of BM-MSCs.https://doi.org/10.1186/s12935-024-03308-2Multiple myeloma (MM)BM-MSCsBiological signaturesTranscriptomic variationCellular viability
spellingShingle Yu Lu
Chaohui Zheng
Wenxia Zhang
Xuan Liu
Ziwei Zhou
Zhenzhen Wang
Huan Hua
Zhengrong Song
Xuejun Zhang
Shuyi Liu
Leisheng Zhang
Fuxu Wang
Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma
Cancer Cell International
Multiple myeloma (MM)
BM-MSCs
Biological signatures
Transcriptomic variation
Cellular viability
title Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma
title_full Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma
title_fullStr Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma
title_full_unstemmed Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma
title_short Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma
title_sort characterization of the biological and transcriptomic landscapes of bone marrow derived mesenchymal stem cells in patients with multiple myeloma
topic Multiple myeloma (MM)
BM-MSCs
Biological signatures
Transcriptomic variation
Cellular viability
url https://doi.org/10.1186/s12935-024-03308-2
work_keys_str_mv AT yulu characterizationofthebiologicalandtranscriptomiclandscapesofbonemarrowderivedmesenchymalstemcellsinpatientswithmultiplemyeloma
AT chaohuizheng characterizationofthebiologicalandtranscriptomiclandscapesofbonemarrowderivedmesenchymalstemcellsinpatientswithmultiplemyeloma
AT wenxiazhang characterizationofthebiologicalandtranscriptomiclandscapesofbonemarrowderivedmesenchymalstemcellsinpatientswithmultiplemyeloma
AT xuanliu characterizationofthebiologicalandtranscriptomiclandscapesofbonemarrowderivedmesenchymalstemcellsinpatientswithmultiplemyeloma
AT ziweizhou characterizationofthebiologicalandtranscriptomiclandscapesofbonemarrowderivedmesenchymalstemcellsinpatientswithmultiplemyeloma
AT zhenzhenwang characterizationofthebiologicalandtranscriptomiclandscapesofbonemarrowderivedmesenchymalstemcellsinpatientswithmultiplemyeloma
AT huanhua characterizationofthebiologicalandtranscriptomiclandscapesofbonemarrowderivedmesenchymalstemcellsinpatientswithmultiplemyeloma
AT zhengrongsong characterizationofthebiologicalandtranscriptomiclandscapesofbonemarrowderivedmesenchymalstemcellsinpatientswithmultiplemyeloma
AT xuejunzhang characterizationofthebiologicalandtranscriptomiclandscapesofbonemarrowderivedmesenchymalstemcellsinpatientswithmultiplemyeloma
AT shuyiliu characterizationofthebiologicalandtranscriptomiclandscapesofbonemarrowderivedmesenchymalstemcellsinpatientswithmultiplemyeloma
AT leishengzhang characterizationofthebiologicalandtranscriptomiclandscapesofbonemarrowderivedmesenchymalstemcellsinpatientswithmultiplemyeloma
AT fuxuwang characterizationofthebiologicalandtranscriptomiclandscapesofbonemarrowderivedmesenchymalstemcellsinpatientswithmultiplemyeloma